R & d- medical: biomedical (basic research)

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201400002C
Awardee
Awarding agency
Obligated
$641,664

Award facts

Opportunity
  • N44CO4700516 Solicitation number
Contract value 86% obligated
  • $641,664.46 Current, with exercised options
  • $749,959.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Other
Place of performance
Rockville, MD 20850, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 3 · A companion diagnosis for prognosis of kidney cancer -$108,295
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $749,959

Quick answers

Who was awarded contract HHSN261201400002C?

HHSN261201400002C was awarded to 20 / 20 Biolabs, Inc. by National Cancer Institute (National Institutes of Health) on February 18, 2014.

How much is contract HHSN261201400002C worth?

The government has obligated $641,664 on HHSN261201400002C. Its potential value, with all options, is $749,959.

Was contract HHSN261201400002C competed?

The extent of competition for HHSN261201400002C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award